nx-2127
nurix therapeutics
['lymphoma', 'dlbcl', 'nhl', 'cll', 'follicular', 'nx-2127 ', 'mantle,(-dismantle)', 'nx-2127', 'nx,2127,001', 'emergent ']
congress | #ash22
anthony mato discussed a phase i trial of nx-2127 in pts with #cll or other b-cell malignancies. nx-2127 degrades wild-type and mutant btk. cytopenias were a common teae across doses. an orr rate of 33% was observed in r/r cll pts, with sustained btk degradation 
A global education platform providing clinical updates on a range of lymphoma subtypes and chronic lymphocytic leukemia (#CLL) #lymsm